Purchases and Sales Made in Q4 2024 in Design Therapeutics, Inc. (DSGN)
This table provides information about the institutional ownership of Design Therapeutics, Inc. (DSGN) during Q4 2024. The information is specifically focused on institutions that hold shares of Design Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jun 30, 2025
Q4 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-35- 0.12% |
$160 - $263
|
28.1K
$140K
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-50- 0.42% |
$228 - $375
|
11.9K
$59K
|
|
Feb 05, 2025
Q4 2024
|
Srs Capital Advisors, Inc.
Denver, CO |
SELL
|
- |
-101- 41.39% |
$461 - $758
|
143
$712
|
|
Feb 14, 2025
Q4 2024
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-151- 1.14% |
$689 - $1.13K
|
13.1K
$65.1K
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-856- 17.39% |
$3.9K - $6.42K
|
4.07K
$20.3K
|
|
Feb 13, 2025
Q4 2024
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-1.43K- 31.9% |
$6.53K - $10.7K
|
3.06K
$15.2K
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-1.65K- 4.49% |
$7.53K - $12.4K
|
35.2K
$175K
|
|
Feb 11, 2025
Q4 2024
|
Simplex Trading, LLC
|
SELL
|
- |
-2.43K- 32.02% |
$11.1K - $18.3K
|
5.17K
$25.7K
|
|
Feb 11, 2025
Q4 2024
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-2.8K- 4.74% |
$12.8K - $21K
|
56.3K
$280K
|
|
Feb 11, 2025
Q4 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-15.6K- 2.67% |
$70.9K - $117K
|
568K
$2.83M
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-20.5K- 7.48% |
$93.5K - $154K
|
254K
$1.26M
|
|
Feb 14, 2025
Q4 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-36.9K- 43.4% |
$168K - $277K
|
48.2K
$240K
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-54.6K- 25.66% |
$249K - $409K
|
158K
$787K
|
|
Feb 07, 2025
Q4 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-55.4K- 31.9% |
$253K - $416K
|
118K
$589K
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-70.5K- 12.1% |
$322K - $529K
|
512K
$2.55M
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-71K- 23.29% |
$324K - $533K
|
234K
$1.16M
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-82.6K- 19.27% |
$377K - $620K
|
346K
$1.72M
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-100K- 32.97% |
$457K - $752K
|
204K
$1.02M
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-107K- 45.5% |
$489K - $804K
|
128K
$639K
|
|
Feb 14, 2025
Q4 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-262K- 93.48% |
$1.19M - $1.97M
|
18.3K
$90.9K
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-290K- 83.65% |
$1.32M - $2.17M
|
56.6K
$282K
|